Analysts Pick XRP as Best 12-Month Bet on $1.6 Billion US Fund Base

On Wednesday, a 12-month outlook published in the United States market ranked XRP first among the three widely held tokens it lined up in an altcoin comparison, even though the coin spent the past month trailing both of its meme rivals. The call landed with the XRP price near $1.34 at 16:00 UTC on Thursday, up 0.6% over 24 hours, after the token closed the 30-day measurement window 1.4% lower. Pepe jumped 21.3% across those 30 days, overwhelming both Dogecoin (DOGE), which added just 0.1%, and XRP, in a quiet stretch for the XRP market. Over the past week the gap narrowed but the order held: PEPE gained 1.2%, while DOGE slid 6.9% and XRP fell 6.7%, leaving PEPE the only one of the three with a meaningful rise on either timeframe. The divergence framed the analysts' question: whether a month of meme momentum or a decade of payment infrastructure says more about the next twelve months.

The three tokens rest on very different foundations. PEPE began as an internet joke, and even its backers point to little use beyond trading; its market cap sits near $1.7 billion, 85.2% below its all-time high. DOGE grew on community and social media attention, carries a longer trading history and a cap near $13.1 billion, 88.5% below its peak. XRP is the native token of the XRP Ledger, a mainnet built for fast cross-border payments, with a market cap of roughly $86.3 billion. Data tracked by SoSoValue puts the net asset value of US XRP funds at about $1.6 billion, a base neither meme coin can match, and the coin sits 62.5% below its high after losing its entire summer range earlier this month.

Zero Inflows for Three Days

Institutional money stayed on the sidelines through the stretch. US Dogecoin funds took in no new capital at all in October, and XRP funds recorded zero net inflows for three consecutive trading days, a run that followed the 13th straight week of inflows logged earlier this month. The analysis read the zeros as institutional withdrawal: investment advisers and asset managers, the buyers those funds depend on, have stepped back for now. Dogecoin's longer record and its $13.1 billion cap did not spare it the stall either, since its own fund complex shows no fresh money for the month. PEPE managed its 21.3% climb without any listed fund and without an exchange listing or partnership to account for it, which leaves the rally resting on retail demand alone; with a cap of only $1.7 billion, a modest wave of selling could erase the month's gains quickly.

The 12-month case for XRP rests on scale and use. Its market cap runs far beyond Dogecoin's, its token does real work settling payments rather than serving trading alone, and the $1.6 billion already parked in US funds offers a ready channel if institutional demand returns in 2027. The analysts flagged risks in both directions. Redemptions from XRP funds would press the price directly, and if banks and other traditional finance payment firms keep using Ripple's network without buying XRP in size, questions about long-term demand sharpen. The comparison set two lines that would change the call: sustained outflows from US XRP funds, or a fall below $1, the level the coin held in mid-August. That $1 marker sits roughly 25% below the current print, close enough that a repeat of this week's weakness would put it in play.

Our own readings frame where the pick stands today. Live monitoring shows XRP at $1.3419, up 0.2% since the analysis was published, still below the $1.3674 resistance that scores 100 out of 100 on our composite scale, where the 50-, 100- and 200-day moving averages converge; the nearest support at $1.3114 carries a score of 89/100, and the full level map sits in our XRP technical analysis. Positioning leans long against a soft tape: funding on crypto futures sits at 0.0058%, the long/short account ratio reads 3.21 with 76.3% of accounts long, and the MACD signal is bearish with an RSI of 39.77 inside a broader downtrend. That downtrend has held since the summer range gave way, and it is the condition, not the 2027 thesis, that the next sessions will test against $1.3674.